A new PLOS Genetics study derives a corrected liability-scale conversion for covariate-adjusted binary GWAS that accounts for ...
Stocktwits on MSN
ImmunityBio treats first patients in Europe with Anktiva plus BCG – retail calls it a great opening act for Q3 earnings
Uniphar will offer supply chain and distribution services across Europe. ・Wall Street expects Q3 revenue of $59.2 million and ...
Grit is selling its KSh 20.5 billion Kenyan property portfolio amid a debt crisis, putting Rosslyn Grove, Buffalo Mall and ...
Medline Inc. ("Medline" or the "Company") (Nasdaq: MDLN), the largest provider of medical-surgical ("med-surg") products and ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the first patients in Europe received treatment with ANKTIVA® (nogapendekin alfa inbakicept) in ...
NEAR is trading at $4.02, just above immediate support at $3.90 and below its short- and medium-term moving averages. A ...
The Regional Council has authorized up to €18,4 million in annual funding for healthcare, but the resources will be decided ...
Sales of $979 million, up from $958 million in Q3 2025 Operating income of $82 million, down from $135 million in Q3 2025, driven by $32 million ...
The Library of Layers architecture challenges fixed transformer execution by letting a model choose which computational block ...
Independent AI forecasts of DC Initiative 86, conditional on the vote, pooled through a causal map - MaxGhenis/dc-i86-llm-forecast ...
Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) announced today that the Toronto Stock Exchange (“TSX”) has accepted its Notice of Intention to Make a Normal Course Issuer Bid (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results